Avodart Soft Capsules 0.5mg (Dutasteride)

Adult dose

The recommended dose of this medication is 1 capsule (0.5mg) once daily. Because exposure to the contents of the capsule may cause irritation of the oropharyngeal mucosa, swallow this medication whole without chewing or breaking it. This medication may be taken with or without food. No dose adjustment is necessary in patients with renal impairment or elderly patients. The recommended dose in patients with hepatic impairment has not been established because no data are available on the use of this medication in these patients.

This medicine should not be handled or taken by women, especially those who are pregnant or may become pregnant. This medication can be absorbed through the skin, so care should be taken to avoid any contact with leaking capsules for women or children. If a capsule breaks and comes into contact with the skin, it should be washed immediately with soap and water. This medication is not to be used in children under 18 years of age, and should also not be taken by those with hypersensitivity or allergies to certain medications. Adult men planning to conceive should use caution and consult a physician, as this medication may affect fertility. Patients with urethral obstruction or severe urine flow reduction symptoms should use caution when taking this medication, as well as those with liver dysfunction. Also, caution is needed when taking strong CYP3A4 inhibitors as drug concentrations may change. During treatment with this medication, side effects related to sexual function such as erectile dysfunction, decreased libido, and ejaculation disorders may occur, and some patients may experience breast pain or breast enlargement. Long-term use of this medication has not significantly increased the frequency of sexual dysfunction or breast disorders; however, it is important to promptly inform medical personnel if any unusual breast symptoms occur. This medication reduces PSA levels that are important for the assessment of prostate cancer risk; therefore, when interpreting PSA tests after taking this medication, baseline values should be considered, and regular checks of prostate status should be conducted. Men taking this medication should undergo regular evaluations for prostate cancer risk, and should promptly inform medical personnel if any changes such as lumps or discharge from the breast are noticed. This medication is known not to significantly impact driving or machine operation abilities, but caution is necessary if any abnormal reactions occur during use. In case of overdose, there is no specific antidote, so appropriate supportive treatment should be given based on symptoms. This medication should be kept out of the reach of children and stored in its original container to prevent misuse or degradation of quality. Additionally, during treatment with this medication, blood donation should not be performed until at least 6 months after the last dose.

• Erectile dysfunction
• decreased libido
• ejaculation disorder
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorders
• dizziness
• rash

This medication should be stored in a sealed container to prevent air from entering, avoiding direct sunlight and keeping it at a cool temperature below 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness and prevent degradation.

Appearance

Light yellow oval soft capsule containing a colorless transparent liquid.

Package unit

30 capsules/box [(10 capsules/PTP x 3)]